JP2017536335A5 - - Google Patents

Download PDF

Info

Publication number
JP2017536335A5
JP2017536335A5 JP2017518100A JP2017518100A JP2017536335A5 JP 2017536335 A5 JP2017536335 A5 JP 2017536335A5 JP 2017518100 A JP2017518100 A JP 2017518100A JP 2017518100 A JP2017518100 A JP 2017518100A JP 2017536335 A5 JP2017536335 A5 JP 2017536335A5
Authority
JP
Japan
Prior art keywords
hal
independently
substituted
sor
cor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518100A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017536335A (ja
JP6835711B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/002008 external-priority patent/WO2016050359A1/en
Publication of JP2017536335A publication Critical patent/JP2017536335A/ja
Publication of JP2017536335A5 publication Critical patent/JP2017536335A5/ja
Application granted granted Critical
Publication of JP6835711B2 publication Critical patent/JP6835711B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518100A 2014-10-01 2015-10-01 ボロン酸誘導体 Expired - Fee Related JP6835711B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14003392 2014-10-01
EP14003392.9 2014-10-01
PCT/EP2015/002008 WO2016050359A1 (en) 2014-10-01 2015-10-01 Boronic acid derivatives

Publications (3)

Publication Number Publication Date
JP2017536335A JP2017536335A (ja) 2017-12-07
JP2017536335A5 true JP2017536335A5 (cg-RX-API-DMAC7.html) 2019-10-17
JP6835711B2 JP6835711B2 (ja) 2021-02-24

Family

ID=51690789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518100A Expired - Fee Related JP6835711B2 (ja) 2014-10-01 2015-10-01 ボロン酸誘導体

Country Status (14)

Country Link
US (1) US10294246B2 (cg-RX-API-DMAC7.html)
EP (1) EP3201207B1 (cg-RX-API-DMAC7.html)
JP (1) JP6835711B2 (cg-RX-API-DMAC7.html)
KR (1) KR102450583B1 (cg-RX-API-DMAC7.html)
CN (1) CN107001390B (cg-RX-API-DMAC7.html)
AU (1) AU2015327346B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017006420A2 (cg-RX-API-DMAC7.html)
CA (1) CA2963205A1 (cg-RX-API-DMAC7.html)
ES (1) ES2873000T3 (cg-RX-API-DMAC7.html)
IL (1) IL251301B (cg-RX-API-DMAC7.html)
MX (1) MX370336B (cg-RX-API-DMAC7.html)
RU (1) RU2017115188A (cg-RX-API-DMAC7.html)
SG (1) SG11201702623TA (cg-RX-API-DMAC7.html)
WO (1) WO2016050359A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2717558C2 (ru) 2014-10-01 2020-03-24 Мерк Патент Гмбх Производные бороновой кислоты
KR20170062518A (ko) 2014-10-01 2017-06-07 메르크 파텐트 게엠베하 보론산 유도체
RU2017115193A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты
DK3672977T3 (da) 2017-08-24 2022-09-26 Merck Patent Gmbh Boronsyrederivater
BR112021001359A2 (pt) * 2018-07-26 2021-04-20 Merck Patent Gmbh derivados de ácido borônico
CN113135944A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物
CN113135943A (zh) * 2020-01-19 2021-07-20 首药控股(北京)有限公司 硼酸衍生物
US20250340577A1 (en) * 2021-03-02 2025-11-06 Case Western Reserve University Beta-lactomase inhibitors and uses thereof
CA3217594A1 (en) * 2021-05-19 2022-11-24 William Guy Whittingham Weed control method
JP2024529468A (ja) 2021-07-29 2024-08-06 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の[(1r)-2-(1-ベンゾフラン-3-イル)-1-{[(1s,2r,4r)-7-オキサビシクロ[2.2.1]ヘプタン-2-イル]ホルムアミド}エチル]ボロン酸の結晶性形態、その付加物、および得るためのプロセス
JP7734276B2 (ja) * 2021-10-14 2025-09-04 ショウヤオ ホールディングス(ベイジン) カンパニー, リミテッド ボロン酸誘導体
WO2023232830A1 (en) 2022-06-02 2023-12-07 Merck Patent Gmbh Boronic acid adducts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
CA2376965A1 (en) * 1999-07-07 2001-01-11 Timothy Patrick Forsyth Peptide boronic acid inhibitors of hepatitis c virus protease
US7271186B1 (en) * 2002-12-09 2007-09-18 Northwestern University Nanomolar β-lactamase inhibitors
MX2010005252A (es) * 2007-11-13 2011-04-11 Novartis Int Pharm Ltd Inhibidores de beta-lactamasa.
AR075090A1 (es) * 2008-09-29 2011-03-09 Millennium Pharm Inc Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
JP6129203B2 (ja) * 2011-12-22 2017-05-17 アレス トレーディング ソシエテ アノニム α−アミノボロン酸誘導体、選択性免疫プロテアソーム阻害剤
RU2717558C2 (ru) 2014-10-01 2020-03-24 Мерк Патент Гмбх Производные бороновой кислоты
KR20170062518A (ko) 2014-10-01 2017-06-07 메르크 파텐트 게엠베하 보론산 유도체
RU2017115193A (ru) 2014-10-01 2018-11-06 Мерк Патент Гмбх Производные бороновой кислоты

Similar Documents

Publication Publication Date Title
JP2017536335A5 (cg-RX-API-DMAC7.html)
JP2018502048A5 (cg-RX-API-DMAC7.html)
CY1122821T1 (el) Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2
ES2649995T3 (es) Benzamidas
AR119454A2 (es) COMPUESTOS ÚTILES COMO MODULADORES DE RORg, SALES FARMACÉUTICAMENTE ACEPTABLES DE LOS MISMOS, COMPOSICIONES FARMACÉUTICAS Y DICHOS COMPUESTOS PARA USO COMO MEDICAMENTO
AR106605A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
EA201891191A1 (ru) 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения
EA201892710A1 (ru) Карбамоилоксиметилтриазолциклогексильные кислоты в качестве антагонистов lpa
AR109788A1 (es) Compuestos de benzo[b]tiofeno como agonistas de sting
EA201692249A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
UY36275A (es) Compuestos aminopirimidinilo
AR106763A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
EA202091505A1 (ru) Триазолазолы циклогексильной кислоты в качестве антагонистов lpa
MX379155B (es) Compuestos que inhiben la proteína mcl-1.
MX380928B (es) Inhibidores de kras g12c.
EA201791304A1 (ru) Производные изохинолина для лечения вич
CR20160525A (es) Pirazolopiridinas y pirazolopirimidinas
PE20180232A1 (es) Derivados de indol mono o disustituidos como inhibidores de la replicacion viral del dengue
AR104963A1 (es) Derivados de 2-(pirazolopiridin-3-il)pirimidina como inhibidores de jak
EA201692265A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
AR106138A1 (es) Compuestos y métodos para inhibir jak
AR102171A1 (es) Compuestos sustituidos de aminopurina, sus composiciones y su uso en el tratamiento o prevención de melanoma
EA201691670A1 (ru) Тетразолонзамещенные дигидропиридиноновые ингибиторы mgat2
AR097866A1 (es) Derivados de 4-azaindol
AR099160A1 (es) Compuestos y composiciones farmacéuticas de los mismos para el tratamiento de trastornos inflamatorios